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Abstract 
Background/Aims: Phosphatases are involved in regulation of MAP kinase (MAPK). 
A431 cells migrate on collagen after EGF stimulation using MAPK. To clarify the 
involvement of PP2A in this MAPK-dependent migration, the expression of an 
isoform of the B regulatory subunit was inhibited. Methods: An antisense sequence 
corresponding to Bβ cDNA was transfected into A431 cells. Their migratory activity on 
collagen was examined using Transwell, and MAPK phosphorylation and 
phosphatase activity were measured, and the results were compared with those 
obtained with mock-transfected cells. Results: Antisense-transfected cells showed 
less Bβ protein and phosphatase activity than mock-transfected controls. Migration of 
antisense-transfected cells showed a low response to EGF. The response of MAPK 
phosphorylation of antisense-transfected cells to EGF stimulation and adhesion to 
collagen in the presence or absence of EGF were markedly decreased. Phosphatase 
activity of PP2A-Bβ also did not respond to EGF, collagen or EGF plus collagen, and 
remained at low levels. Conclusion: These results suggested that PP2A-Bβ  promotes 
cell migration through the MAPK cascade. 
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Introduction 
 Cell migration requires stimulation by a motogenic cytokine and cell adhesion to the 
extracellular matrix, which is mediated by integrins [1-3]. Epidermal growth factor (EGF) is a 
motogenic cytokine for a variety of cell types [4, 5]. EGF-induced signalling for migration 
begins with binding of EGF to EGF receptors, which then deliver a signal to a protein kinase 
cascade involving Raf-1 kinase, MEK and MAP kinase (MAPK) via Ras [6, 7]. Cell adhesion 
to the extracellular matrix induces assembly of distinct integrins at focal contacts and also 
activates the MAPK cascade [8, 9]. EGF and adhesion to collagen (COL) activate MAPK 
synergistically in A431 cells, and the resultant sustained MAPK activation leads to migration 
[10]. 
 The activation of kinases is controlled by phosphatases [11-13]. A balance of kinases 
and phosphatases is necessary for cells to maintain an appropriate level of the transducing 
signal for migration. However, phosphatases have been studied less intensively than kinases, 
and the regulatory mechanism of MAPK activation by phosphatases is not yet fully 
understood. Both serine/threonine phosphatases and a serine/threonine/tyrosine phosphatase 
are likely to be involved in regulation of the MAPK cascade [14-19]. On the other hand, the 
serine/threonine phosphatases PP1 and PP2A are known to regulate cell motility [20-22], and 
several studies have indicated that PP2A regulates MAPK signalling [15, 16, 23]. 
  PP2A is a holoenzyme consisting of a heterotrimer of a 65-kDa structural subunit A, 
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a 55-130 kDa regulatory subunit B, and a 36 kDa catalytic subunit C. The B regulatory 
subunits are divided into B, B' and B'' families, which show little homology to each other. 
These molecules are encoded by many genes and have many splicing variants. The B family 
proteins, Bα, Bβ, Bγ, and Bδ [24, 25], and the B' family proteins, B'α, B'β, B'γ, B'δ and B'ε 
[26], are all 54-57 kDa in size. The B'' family consists of PR72/130, PR48 and PR59 [27-29]. 
A B''' family, consisting of PR93 and PR110, has also been reported recently [30]. At present, 
a total of 20 B subunit proteins are known, including splicing variants of Bβ, B'γ, B'δ and 
PR72/130 [11-13]. The diversity of B regulatory subunits is considered to be due to the 
functional complexity of PP2A, which is involved in several basic phenomena, such as cell 
cycle regulation [11-13] and tumour progression [21, 31-33]. Studies to identify the substrate 
specificities and the functions of the various isoforms are currently in progress. Bα regulates 
the cell cycle through microtubule-associated proteins [34], B'α blocks the Wnt signal, acting 
on APC [35], and B'γ1 acts on paxillin in focal contacts and regulates cell motility [31]. 
Recent studies indicated that the B subunit targets PP2A to the MAPK cascade, while the B' 
subunit regulates apoptosis [36-38]. Thus, it is necessary to analyze the isoforms involved, 
especially the B isoforms, to understand the signal transduction pathway involved in 
MAPK-mediated migration. 
 In the present study, we focused on the role of one isoform, PP2A-Bβ, which has 
only one B isoform, expressed in a carcinoma cell line. Our results represent evidence for 
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regulation of MAPK-mediated migration by PP2A-Bβ. 
Materials and Methods 
 Cell culture. A human oesophageal squamous carcinoma cell line, A431, was used (Human 
Science Research Resource Bank, Osaka, Japan). The cells were maintained as subconfluent 
cultures in Eagle’s minimum essential medium (MEM, Sigma, St. Louis, MO, USA) 
containing 10% foetal bovine serum (FBS, GIBCO BRL, Grand Island, NY, USA). Cells were 
starved of serum on 10-cm tissue culture dishes for 18 h in medium containing 1% FBS for 
1 day before the experiment. The cells were harvested with 0.25% trypsin, which was then 
inactivated with 0.25% soybean trypsin inhibitor (Sigma). The cells were washed with 
serum-free medium containing 0.5% heat-denatured bovine serum albumin (BSA, Sigma), 
suspended in BSA/MEM, and incubated for 30 min at 37°C for the experiments. 
 Construction of the antisense expression vector and transfection. A search for homology 
between PP2A-Bβ and other B subunits was performed (there is poor homology among 
families of the B regulatory subunit, but high homology within a given B family), and a 
sequence without high homology was found at positions –10 to +386. There was 70.2% 
homology between α and β, and 75.8% homology between α and γ isoforms. The sequence of 
the upstream primer was selected as GCTCTAGACCTGCTGTCAATGGAGGAGGA (XbaI 
recognition site is underlined) and that of the downstream primer was 
CCCAAGCTTCCTTCTGGCCTCTTATCACGC (HindIII recognition sequence underlined). 
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The PCR product was subcloned into pcR2.1 using a TOPO TA cloning kit (Invitrogen, 
Carlsbad, CA, USA). The inserted DNA was sequenced with an autosequencer (Amersham 
Pharmacia Biotech, Piscataway, NJ, USA), cut out with HindIII and XbaI (Toyobo, Osaka, 
Japan), and inserted into the mammalian expression vector pcDNA3.1 (Invitrogen), which 
was linearised at the multicloning site with the same restriction enzymes. The DNA was 
inserted into pcDNA3.1 in the antisense orientation. The antisense-containing expression 
vector was transfected into A431 cells using Effectene Transfection Reagent (QIAGEN, 
Hilden, Germany). Transformed A431 cells were cloned by selection with 400 µg/ml G418 
(Sigma). The cells were maintained in 40 µg/ml of G418, and the medium was changed to 1% 
FBS/MEM without G418 on the day before the experiment. Mock-transfected cells were used 
as controls. 
 Reverse transcription (RT)-PCR. Total RNA was extracted from the cells by the acid 
guanidinium-phenol-chloroform method. Contaminating DNA was removed by incubation 
with RNase-free DNase I (Nippon Gene, Toyama, Japan) for 30 min at 37°C. The extracted 
total RNA (1 µg) in a volume of 20 µl was transcribed to cDNA using AMV reverse 
transcriptase (Promega, Madison, WI, USA) for 10 minutes at 42°C, and then the reaction 
mixture was heated for 5 minutes to inactivate the enzyme. The resultant cDNA solution (0.5 
µl) was used for PCR. The sequences of the primers for detecting isoforms of PP2A B 
subunits are listed in Table 1. The reactions were performed using KOD-DNA polymerase 
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containing anti KOD-polymerase (Toyobo), and were run in a thermal cycler (Applied 
Biosystems, Foster City, CA, USA) under the following conditions: 94°C/2 min for 1 cycle; 
94°C /15 s, 55°C /30 s, 68°C /40 s, for 35 cycles. Amplified DNA was separated on 2% 
agarose gels containing 2 µg/ml ethidium bromide and visualised under ultraviolet irradiation. 
 Migration assay. Cell migration assays were performed in 24-well Transwell chambers 
containing a polycarbonate membrane with a pose size of 8 µm (Costar, Cambridge, MA, 
USA). The undersurface of the membrane was coated with 10 µg/ml type I COL (Nitta 
Gelatin, Osaka, Japan) in phosphate-buffered saline at 4°C overnight. Aliquots of 50,000 cells 
were treated with 10 ng/ml EGF (Genzyme, Cambridge, MA, USA) for 30 min at 37°C. The 
resuspended cells were washed by centrifugation, loaded onto membranes in quadruplicate, 
and incubated in a CO2 incubator at 37°C for 18 to 20 h. The cells that migrated on the 
COL-coated surface were stained with 2% crystal violet (Sigma). The membranes were 
washed with water, the dye was eluted with 10% acetic acid, and the optical density of the 
eluate at 620 nm was measured. The background optical density was evaluated on 
BSA-coated membranes, and was subtracted from all data points. When the number of 
migrated cells was too small to apply the colourimetric assay, the cells were counted directly 
under a microscope. 
 Western blotting. Cells were lysed with sodium dodecyl sulphate (SDS) sample buffer (62.5 
mM Tris-HCl buffer, pH 6.8, 2% SDS, 10% glycerol, 0.1% bromophenol blue, 6% 
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mercaptoethanol), and sonicated. Then, the samples were heated at 95°C for 5 min and 
centrifuged for 5 min. Supernatants were collected and protein content was determined using 
a Protein Assay kit (Bio-Rad, Hercules, CA, USA). Samples containing 50 µg of protein were 
subjected to 10% SDS-polyacrylamide gel electrophoresis and transferred onto 
polyvinylidene fluoride membranes (Perkin-Elmer Life Sciences, Boston, MA, USA). The 
membranes were reacted with anti-phospho-ERK1/2 (Thr202/Tyr204) antibodies (New England 
BioLabs, Beverly, MA, USA) or anti-PP2A- Bα/β antibodies (Santa Cruz Biotechnology, 
Santa Cruz, CA, USA). Anti-ΕΡΚ1/2 antibodies (New England BioLabs) were also used to 
confirm equal loading of protein samples. The membranes were washed, and then reacted 
with peroxidase-linked anti-rabbit IgG antibodies (Cell Signaling, Beverly, MA, USA) or 
peroxidase-linked anti-goat IgG antibodies (Santa Cruz). Visualisation was performed using a 
chemiluminescence system (ECL western blotting detection reagent, Amersham Pharmacia 
Biotech). The blots were scanned with a computer-assisted scanner and the band densities 
were analyzed with NIH Image software. Anti-phospho-ERK1/2, anti-ERK1/2, 
anti-PP2A-Bα/β, peroxidase-linked anti-rabbit IgG and peroxidase-linked anti-goat antibodies 
were diluted at 1:1,000, 1:1,000, 1:1,000, 1:2,000 and 1:2,000, respectively. Bα and Bβ 
proteins could not be distinguished by western blotting using anti-Bα/β antibodies as both 
have a molecular weight of 55 kDa. However, we regarded the data obtained with anti-Bα/β 
antibodies as reflecting Bβ protein because Bα mRNA was not detected by highly sensitive 
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RT-PCR. 
 Measurement of phosphatase activity. A fluorescence assay method [39] was employed to 
determine phosphatase activity. Aliquots of 4×106 cells were lysed with lysis buffer (50 mM 
Tris-HCl buffer, pH 7.5, 150 mM NaCl, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1 
mM phenylmethylsulfonyl fluoride, 2 µg/ml aprotinin, 1 µg/ml leupeptin, 10 mM 
mercaptoethanol) and sonicated. The samples were centrifuged at 14,000 rpm for 10 min. The 
protein concentration in the supernatant was measured, and the samples containing the same 
protein content were used. Polyclonal anti-PP2A-Bα/β antibodies were added to the 
supernatant, and the mixtures were incubated at 4°C for 90 min. Protein G-Sepharose 
(Amersham Pharmacia Biotech) was added, and the mixtures were rocked at 4°C for 2-3 h. 
Protein G-Sepharose with bound immune complexes was washed with lysis buffer several 
times. The buffer was changed to phosphatase assay buffer (50 mM Tris-HCl buffer, pH 7.0, 
0.1 mM CaCl2), and incubation was conducted at 37°C, followed by reaction with 
4-methylumbelliferyl phosphate (Wako Pure Chemical Industries, Osaka, Japan), and the 
fluorescence intensity of the resultant 4-methylumbelliferone was measured with an emission 
wavelength of 450 nm and excitation wavelength of 360 nm. As a reference, the supernatants 
of cells were diluted serially beginning with 4×106 cells, processed sequentially under the 
same conditions without reaction with the antibodies, and the fluorescence intensities were 
plotted. We defined the fluorescence intensity of 4×106 cells with 4-methylumbelliferyl 
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phosphate as 1 artificial unit (AU). 
 Immunofluorescence. Slide glasses with 8 plastic chambers (Lab-Tek Chamber Slides, Nunc, 
Roskilde, Denmark) were coated with 10 µg/ml COL. Aliquots of 10,000 cells were loaded 
onto each well, and incubated at 37°C for 90 min. Cells were fixed with 3% 
paraformaldehyde for 10 min, permeabilised with 0.01% Triton X-100 for 3 min, and blocked 
with 2% BSA, and then incubated for 90 min with anti-PP2A-Bβ antibodies (Calbiochem, 
Darmstadt, Germany) at 1:10 dilution, or anti-PP2A-Bα/β antibodies at 1:10 dilution. The 
cells were then reacted for 30 min with FITC-conjugated anti-rabbit antibodies (ICN, Costa 
Mesa, CA, USA) or FITC-conjugated anti-goat antibodies at 1:200 dilution at room 
temperature. As a negative controls FITC-conjugated anti-rabbit antibodies were reacted with 
cells without primary antibodies. 
 Statistics. Student’s t-test was used for comparison of the averages between two groups. 
Two-way analysis of variance was used for comparison of kinetic data between two groups.  
Results 
PP2A-Bβ is Commonly Expressed in Squamous Carcinoma Cell Lines 
 Twenty isoforms and splicing variants of the PP2A B subunit have been reported 
[11-13]. We investigated their expression in A431 squamous cell carcinoma cells and other 
squamous carcinoma cell lines (Calu-1, VMRC-LCP and HSC-3) by RT–PCR. The results 
showed that Bβ, B'β, B'γ1 and B'δ2 were expressed in A431 cells (Table 1). Furthermore, Bβ 
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was expressed in all of the squamous carcinoma cell lines examined (Fig. 1). Cell migration 
of stratified squamous epithelia is a universal phenomenon, occurring for example in wound 
healing, and it is likely that a particular phosphatase would be involved in regulation of 
migration among many cells of similar origin. Furthermore, recent studies suggested that B 
isoforms, but not the B' isoforms, are involved in regulation of the MAPK cascade [36-38]. 
Therefore, we chose the Bβ regulatory subunit of PP2A to analyse the regulatory mechanism 
of migration. 
Bβ Antisense-transfected Cells Show Decreased Protein Expression and Phosphatase Activity 
of PP2A-Bβ 
 Bβ antisense DNA was transfected into A431 cells to inhibit the expression of 
PP2A-Bβ. To confirm the inhibitory effect, we examined the protein expression level of Bβ 
by western blotting using anti-PP2A-Bα/β antibodies in three antisense-transfected clones 
selected at random from ten clones. Three clones of mock-transfected cells were used  as 
controls. Bands at the position of 56 kDa were found in all cell lysates. The density of Bβ in 
antisense-transfected cells was decreased to 58.8 ± 20.1% (mean ± standard deviation, n=9) of 
that in mock-transfected cells (P<0.05) (Fig. 2A). Next, we measured PP2A- Bβ phosphatase 
activity by immunoprecipitation using anti-PP2A-Bα/β antibodies. The average phosphatase 
activity in the mock-transfected cells was 0.224 ± 0.0434 AU, and that in the 
antisense-transfected cells was 0.108 ± 0.0127 AU. The activity of the antisense-transfected 
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cells was 48.2% of that of the mock-transfected cells (P<0.05) (Fig. 2B). One of the 
antisense-transfected cell clones was chosen for the following experiments.  
Bβ Αntisense Decreases EGF- and COL-induced Migratory Activity 
 To examine the effect of decreased PP2A-Bβ, we performed migration assay using 
antisense-transfected cells on COL. The time course of migration was examined using one 
clone each of antisense-transfected (M4) and mock-transfected cells (AS8). The migratory 
ability of antisense-transfected cells was clearly weakened in both the presence and absence 
of EGF as compared to mock-transfected controls (Fig. 3A). MTT assay was also performed 
to determine whether the antisense-transfected cells were viable or not. Microscopically all 
the cells were adhered to collagen when the cells were loaded onto COL and incubated for 9 
hours, and the result of MTT assay [40] showed no difference between antisense-transfected 
cells and mock-transfected cells (Fig. 3B). Furthermore, the difference in migration in the 
presence and absence of EGF was larger in the mock-transfected cells than in the 
antisense-transfected controls (Fig. 3A). Next, we calculated the enhancing effect of EGF on 
migration for 20 h using 3 clones of antisense-transfected cells as follows: migration with 
EGF/ migration without EGF (%). As shown in Fig. 3C, antisense transfection reduced the 
enhancing effect of EGF on migration on COL. 
PP2A-Bβ Assembles in Focal Contacts in A431 Cells, but not in Antisense-transfected Cells 
 After treatment with or without EGF for 30 min, cells were loaded on COL, 
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incubated in a CO2 incubator for 90 min, and morphological changes were examined under a 
microscope. Most of the A431 cells without EGF were round and a few cells were slightly 
elongated 90 min after adhesion to COL. Following pre-treatment of A431 cells with EGF, 
many of the cells had cytoplasmic extensions or were polygonal 90 min after adhesion to 
COL. Antisense-transfected cells without EGF were round on COL. Even when treated with 
EGF, the antisense-transfected cells did not show elongation of their cytoplasmic extensions 
and showed little morphological difference from cells treated without EGF.  
 We further examined the localisation of Bβ protein immunohistochemically. Bβ was 
not detected in round or polygonal A431 cells on COL. However, Bβ was immunolocalised at 
the base of short cytoplasmic extensions of EGF-stimulated A431 cells after adhesion to COL 
(Fig. 4).  
MAPK Phosphorylation Stimulated by EGF and/or COL is Decreased in Antisense 
-transfected Cells 
 A MAPK cascade activated synergistically by EGF and COL is involved in signal 
transduction leading to migration of A431 cells [10]. To ascertain whether PP2A-Bβ controls 
MAPK phosphorylation, we examined the effects of PP2A-Bβ on EGF- and/or COL-induced 
activation of MAPK. In the absence of EGF, the average band density on western blotting of 
the mock-transfected cells using anti-phosphorylated MAPK antibodies decreased to 70.2% 
of that of antisense-transfected controls (Fig. 5A). Next, we examined the response of MAPK 
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phosphorylation in EGF-stimulated cells. The results indicated that phosphorylation of MAPK 
after stimulation with EGF was elevated, reaching the maximal level at 15-30 min, and 
returned to the control level after 60 min, whereas antisense-transfected cells lacked the 
response to EGF (Fig. 5B, C). No changes were observed in MAPK after stimulation with 
EGF within the time frame examined (Fig. 5B). To determine the amount of phosphorylated 
MAPK, samples showing the maximal level of phosphorylated MAPK were diluted serially 
and subjected to western blotting (Fig. 5B). In the mock-transfected cells, MAPK 
phosphorylation increased within 15-30 min after adhesion to COL and then returned to the 
initial level, while the antisense-transfected cells showed no response to COL (Fig. 5D). 
When cells were treated with EGF for 30 min and then immediately loaded onto plates coated 
with COL, there was an increase in level of phosphorylated MAPK in the mock-transfected 
cells within 15 min and this was maintained until 60 min. In contrast, the 
antisense-transfected cells did not respond as strongly (Fig. 5E). 
Weak Effect of EGF and/or COL on PP2A-Bβ Αctivity in Antisense-transfected Cells 
 We measured the kinetics of PP2A-Bβ phosphatase activity induced by EGF and/or 
COL. When mock-transfected cells were treated with EGF, PP2A-Bβ phosphatase activity 
reached a minimum within 15-30 min and returned to the initial level after 45-60 min 
(Fig. 6A). After adhesion to COL, PP2A-Bβ phosphatase activity decreased after 30 min, and 
recovered after 45-60 min in the mock-transfected controls, showing a pattern reciprocal to 
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that of MAPK (Fig. 6B). After stimulation with both EGF and COL, PP2A-Bβ activity in the 
mock-transfected cells decreased within 15 min, and maintained the decreased level until 60 
min (Fig. 6C). The patterns of the kinetics were reciprocal to the kinetics of MAPK in the 
mock-transfected cells. That is, EGF activated MAPK and deactivated PP2A-Bβ 
synchronously. On the other hand, the antisense-transfected cells exhibited low levels of 
PP2A-Bβ activity and lacked the response of PP2A-Bβ activation to EGF, COL and EGF plus 
COL (Fig. 6A, B, C). These results also indicated that the antisense-transfected cells, which 
had low levels of activity of PP2A-Bβ and MAPK, had low migratory activity. Furthermore, 
the antisense-transfected cells, in which PP2A-Bβ and MAPK activities did not respond to 
stimulation, showed low migratory responses. 
Discussion 
 Our results indicated that PP2A-Bβ promoted EGF- and COL-induced cell migration. 
As the EGF-induced migration of A431 cells on COL is regulated by convergent signalling 
for MAPK activation from EGF receptors and integrins [10], PP2A-Bβ should be associated 
with MAPK signalling. Indeed, the results of the present study indicated that phosphorylation 
of MAPK in response to EGF and/or COL was suppressed in Bβ−antisense-transfected cells. 
Nevertheless, PP2A seems to down-regulate MAPK, because PP2A and MAPK activation 
have been reported to show an inverse correlation [23, 41]. Furthermore, several recent 
studies have indicated negative regulation of the MAPK cascade by PP2A. SV40 small T 
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antigen binds to PP2A and subsequently activates MAPK [17, 42]. PP2A forms a molecular 
complex with Shc, and regulates Shc tyrosine phosphorylation and downstream mitogenic 
signalling [43]. In contrast, Bγ has recently been identified as a subunit that promotes 
neuronal differentiation by activating MAPK [44]. The diversity of isoforms could account 
for this difference, but PP2A-Bβ activation of mock-transfected A431 cells was inversely 
correlated with MAPK phosphorylation in the present study. Therefore, the dephosphorylation 
of a protein involved in the MAPK cascade by PP2A-Bβ should up-regulate MAPK, while 
phosphorylation should have a down-regulatory effect. 
 PP2A may interact with MAPK, MEK or Raf-1 in the MAPK cascade. MAPK is 
activated through phosphorylation of Thr202 and Tyr204 by MEK [45]. Allessi et al. [14] 
reported that PP2A dephosphorylated Thr202 of MAPK. The phosphorylation of Thr202 of 
MAPK is also a signal that is necessary for the transient translocation of MAPK to the 
nucleus [46]. The signal for migration of A431 cells requires MAPK translocation to the 
nucleus, as MAPK regulates the production of proteins necessary for migration, including 
AP-1 [5, 10]. However, dephosphorylation inactivates MAPK. Moreover, Bβ was not 
localised in the nucleus in the present study. In contrast, Raf-1 has been shown to be localised 
in the cytoplasm [47], and is membrane-bound following stimulation [48]. It has been 
reported that PP2A binds directly to Raf-1 and dephosphorylates Raf-1 [49]. Phosphorylation 
of Ser259 inactivates Raf-1, and dephosphorylation of this position by PP2A activates Raf-1 
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[49]. Thus, Raf-1 or other phosphoproteins upstream of Raf-1, which may be localised at 
focal contacts, are candidate substrates for PP2A-Bβ.  
 It has been shown that localisation of PP2A is dependent on the B subunits. Bα 
colocalises with microtubules [34], B'α, B'β, B'γ1 and B'ε  are localised in the cytoplasm 
and B'γ3 and B'δ are localised in the nucleus [26, 31, 50, 51]. The localisation of Bβ has not 
been investigated previously. We determined the localisation of PP2A-Bβ by 
immunofluorescence analysis. Bβ assembled in the cytoplasmic extensions after treatment 
with EGF on COL. B'γ3 and B'δ1, 2 have a nuclear localisation signal, 
(K/R)(K/R)XXXXXXXXXXKXXKK [51-53], which mediates their transport to the nucleus 
[54, 55]. A database search indicated that, with the exception of B'γ3 and B'δ1, 2, the PP2A B 
subunit proteins (including Bβ) do not have this sequence, supporting the cytoplasmic 
localisation of Bβ.  
 The other reported PP2A isoform that is correlated with cell motility is PP2A-B'γ1, 
which binds to paxillin on focal contacts and inactivates it by dephosphorylation; a defect of 
B'γ1 has been shown to facilitate cell locomotion [31]. As this isoform, Bγ, was shown to be 
expressed in A431 cells in the present study, cell migration may be regulated by multiple 
isoforms. Furthermore, PP2A-Bβ was expressed ubiquitously in the squamous cell carcinoma 
cell lines A431, HSC-3, VMRC-LCP and Calu-1. Therefore, we concluded that the isoform 
PP2A-Bβ participates in a common cell motility mechanism involved in the migration of 
 18
squamous carcinoma cells.  
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Fig. 1. Expression of PP2A-Bβ in a variety of squamous carcinoma cell lines, A431, Calu-1, 
HSC-3 and VMRC, evaluated by RT-PCR. Total RNA was extracted from the cells and 
reverse transcribed into cDNA, which was then amplified using a primer set for detection of 
Bβ. The PCR products were electrophoresed on 2% agarose gels.  
Fig. 2. Effects of Bβ antisense-transfected A431 cells on protein expression and phosphatase 
activity. Clones of pcDNA3.1/Bβ antisense-transfected and mock-transfected cells were 
selected with G418. Three clones of mock-transfected cells (M2, M3, M4) and 3 clones of 
antisense-transfected cells (AS1, AS8, AS10) selected at random were used. (A) Whole-cell 
lysates (50 µg of protein) were run in 10% polyacrylamide gel under reducing conditions. 
Western blotting was performed with anti-Bα/β antibodies. The densities of the bands of 
protein Bβ appearing at 55 kDa were measured and the results are shown as a bar chart. (B) 
Phosphatase activity of PP2A-Bβ was measured. Protein immunoprecipitated with 
anti-PP2A-Bα/β and immobilised Protein G was allowed to react with 4-methylumbelliferyl 
phosphate, and the fluorescence intensity was measured. Phosphatase activities are expressed 
in artificial units (AU) and percentages are shown. For details, see Materials and Methods. 
Each bar shows the mean ± standard deviation of three clones assayed in triplicate (n=9). 
Fig. 3. Effects of PP2A-Bβ antisense on cell migration on COL. (A) Antisense-transfected 
cells (AS8) treated with (open circles) or without EGF (closed circles), and mock-transfected 
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cells (M4) treated with (open squares) or without EGF (closed squares) were loaded on 
Transwell chambers, and allowed to migrate on COL for 3, 6 and 9 h. The cells were stained 
with crystal violet, and the numbers of cells in 5 square areas were counted under a 
microscope. (B) Viability of cells was examined. Cells were allowed to adhere for 9 hours on 
a 24-well plate coated with COL. Non-adherent cells were removed and adherent cells were 
quantified with a MTT assay. (C) Cells loaded on Transwell chambers were allowed to 
migrate on COL-coated surfaces for 20 h. Migrated cells were stained with crystal violet, 
eluted with 10% acetic acid, and the absorbance of the eluate at 620 nm was measured. The 
ratios of migration with/without EGF (%) were calculated, and are plotted in a bar chart. The 
bar chart and the line chart show means ± standard deviation of four replicate wells.  
Fig. 4. Immunofluorescence of Bβ. Cells were treated with or without 10 ng/ml of EGF for 
30 min. EGF was washed out, and the cells were loaded onto COL-coated slide glasses. 
Ninety minutes after adhesion to COL, cells were fixed with 4% paraformaldehyde, 
permeabilised with Triton X-100 and immunostained with anti-PP2A-Bβ antibodies. 
Although A431 cells without EGF did not show immunofluorescence (A), PP2A-Bβ was 
immunolocalised at the base of cytoplasmic extensions of A431 cells treated with EGF in a 
pattern of focal contacts (B). The results were similar when immunofluorescence analysis was 
performed using anti-PP2A-Bα/β antibodies. 
Fig. 5. MAPK phosphorylation. (A) Three clones of mock-transfected cells (M2, M3 and M4 
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cells) and 3 clones of antisense-transfected cells (AS1, AS8 and AS10 cells) were lysed. The 
whole cell lysates were subjected to western blotting using anti-phosphorylated MAPK 
antibodies. Anti-MAPK antibodies were also used as loading controls for similar amounts of 
proteins. (B) Antisense-transfected cells (AS8 cells) and mock-transfected cells (M4 cells) 
were treated with 10 ng/ml EGF and incubated for 15, 30, 45 and 60 min. Cells were lysed 
and subjected to western blotting using anti-phosphorylated MAPK or anti-MAPK antibodies. 
Samples diluted to 1/8, 1/4 and 1/2 from the 15-minute EGF stimulation sample were run 
simultaneously to ensure that the densities of the blots were dependent on the amount of 
phosphorylated MAPK. (C) The same experiments as shown in B are depicted in a line chart. 
AS8 cells (closed squares) and M4 cells (open squares) were treated with EGF, and western 
blotting analysis was performed using anti-phosphorylated MAPK. The densities of the bands 
were measured. Each bar shows the mean ± standard deviation of triplicate samples. (D) AS8 
cells (closed squares) and M4 cells (open squares) were loaded onto COL-coated plastic 
dishes without EGF. The cells were lysed at 15, 30, 45 and 60 min after loading. (E) AS8 cells 
(closed squares) and M4 cells (open squares) were treated with 10 ng/ml EGF, loaded 
immediately onto COL-coated dishes, and incubated for 15, 30, 45 and 60 min. MAPK 
phosphorylation is shown as the percentage of the density of the phosphorylated MAPK of 
M4 or AS8 cells in suspension without EGF. 
Fig. 6. PP2A-Bβ activities in AS8 cells (closed squares) and M4 cells (open squares). 
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Phosphatase activities of PP2A-Bβ trimer were measured by fluorescence assay using 
anti-Bα/β antibodies. (A) Cells were treated with 10 ng/ml EGF and incubated for 15, 30, 45 
and 60 min. (B) Cells were loaded onto COL without EGF. The cells were lysed at 15, 30, 45 
and 60 min after loading. (C) Cells were treated with 10 ng/ml EGF, loaded immediately onto 
COL, and incubated for 15, 30, 45 and 60 min. Phosphatase activities are shown as 









A431 Calu-1 VMRC HSC-3
PPP2R2A Bα 5’GGAGCTGGAGGAGGGAATGAT3’ 236 NM002717 - - + + 
  5’TCATGGCTCTGGGAAGGTGCTG3’       
PPP2R2B Bβ 5’CCAACAGCTATGCGACCGAAG3’ 320 NM004576 + + + + 
  5’CACGCTCGCTGACTTTCCACA3’       
PPP2R2C Bγ 5’GAGGACACGGACACGCGGAAAA3’ 322 AF086924 - - + - 
  5’TGGACAGGAGTGAGTGGGCG3’       
PPP2R5A B'α 5’GCAAGGCGCAGAGGCAGAAGC3’ 374 NM006243 - - + + 
  5’GGCCTCAAGCGTGGGGTTCATCC3’       
PPP2R5B B'β 5’GAGAGGAAGCTGCCCCCTGC3’ 288 NM0062244 + - - + 
  5’GAGGTCGGCCACACAGTCCAAG3’       
PPP2R5C B'γ1 5’CCTACGGGAGCGGAATTTGACC3’ 994 L42375 + - + - 
  5’GCCAAAGCCAATCCCCAGGTAC3’       
 B'γ 2 5’CCTACGGGAGCGGAATTTGACC3’ 1041 L42375 - +  + + 
  5’CTCGGACTTGCGGAGTGCAAGAGG3’       
 B'γ 3  1158 NM002719 - - - - 
         
PPP2R5D B'δ1 5’GAGAAGGAGCCCCCCAAGGTT3’ 585 L76702 - -  + - 
  5’AGGGTGGGCTCATCTTCCTCTG3’       
 B'δ2  491 L76702 + - - - 
         
PPP2R5E B'ε 5’CTCAGCACCAACTACTCCTCC3’ 391 L76703 - - - - 
  5’GCTGTCACTAGGAGGGAGAG3’       
PPP2R3 B''/PR72 5’TTGCCGCTGAGGAGTATGAGAC3’ 195 NM002718 - - - - 
  5’CCGGCAGCTATTCTTCATCCAC3’       
 B''/PR130  492 NM002718 - - - - 
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Table 1. A list of primers used for detection of B regulatory subunits of PP2A and the results 
of RT-PCR. To detect expression of mRNAs of Bβ isoforms or splicing variants, RT-PCR was 
performed using the primer pairs listed in Table 1. The PCR products were subjected to 
agarose gel electrophoresis, and bands were visualised with ethidium bromide. A part of the 
band pattern is shown in Fig. 3.  
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